Updates
QR code: Mwakilishi app on Google PlayGet the Mwakilishi appFree on Google PlayKenya diaspora news on your phone, free on Google Play. Scan the code with your phone's camera to install.Get the app
AdvertisementTop banner · 970×90 / 728×90
Kenya

Kenya Receives 1.025 Million Doses of COVID-19 Vaccine from COVAX

Kenya Receives 1.025 Million Doses of COVID-19 Vaccine from COVAX

Kenya has received 1.025 million doses of the AstraZeneca-Oxford COVID-19 vaccine from the COVAX facility.

AdvertisementIn-article ad

A Qatar Airways flight QR1341 carrying the first consignment of the COVID-19 vaccine landed at the Jomo Kenyatta International Airport (JKIA) in Nairobi at 11:23 pm on Tuesday.

The delivery was received by top government officials led by Health Cabinet Secretary Mutahi Kagwe, who indicated that the vaccination process will begin with healthcare workers, then police, and teachers.

“The country has 400,000 health care workers and they shall be the first ones to be vaccinated. We need a priority list because we cannot vaccinate everybody at the same time,” Kagwe said at JKIA.

The vaccines were brought in as part of the COVAX, a global initiative that was created to ensure that low and middle-income countries have fair access to vaccines.

The jabs were ferried to a government storage facility in Kitengela, Kajiado County, from where they will be distributed across the country. The vaccines are expected to land at county hospitals by Friday.

“The vaccines will be distributed across all the counties where it will be rolled out to regional hospitals and down to level 3 and level 2 hospitals,” CS Kagwe added.

Kagwe described the arrival of the vaccine in the country as an exciting moment for Kenya, adding that vaccination will be purely voluntary.

“We have been fighting the pandemic with rubber bullets but what we have received is an equivalent to machine guns and tanks,” Kagwe added.

“There are those who would wish not to be vaccinated but we hope it will be a majority of them willing to be vaccinated.”

Comments (4)

Comments are reviewed before they appear. Please keep it respectful.

  1. Settled NomadMar 3, 2021

    The effectiveness of the AstraZenica-Oxford vaccine is dubious, at best. Because of shoddy research and testing, no one is sure of how effective it is. Kenya and Africa should be thinking of how to mass produce the Russian vaccine, Sputnik, which is proven to be more than 90 percent effective, because the Russians are willing to bypass copyright laws and give the formula of how to produce it to Africans. Africans should then enter into negotiations with India, the largest producer of Vaccines in the World, on the modalities of delivering it. I believe this is a way to get a quality product. I believe that the AstraZenica-Oxford vaccine is being availed to Africans because it has not been accepted in the West, despite being the first one to begin trials there.

  2. KamaaMar 4, 2021

    I agree with you on this one, This vaccine is yet to be approved by the FDA. Most West countries including Germany have rejected it.

  3. GuestMar 3, 2021

    It is still better than nothing

  4. Ex diasporanMar 4, 2021

    @Settled Nomad :we are using miti shamba as our vaccine, that's why we are having less deaths than the west

AdvertisementMore stories (Google matched content)

More from Kenya